Alnylam Pharmaceuticals, Inc. (ALNY)
Alnylam Pharmaceuticals, Inc. Revenue
| Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4,278.0K | $5,716.0K | $26.9M | $50.9M | $96.2M | $100.5M | $100.0M | $82.8M | $66.7M | $47.2M | $50.6M | $41.1M | $47.2M | $89.9M | $74.9M | $219.8M | $492.9M | $844.3M | $1,037.4M | $1,828.3M |
Alnylam Pharmaceuticals, Inc. (ALNY) Revenue comparison analysis
ALNY key stats
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
investors
worldwide
FAQ
1) What is Alnylam Pharmaceuticals, Inc.'s Revenue?
As of today, Alnylam Pharmaceuticals, Inc.'s last 12-month Revenue is $2,094.8M, based on the financial report for Sep 30, 2024 (Q3 2024).
2) What is Alnylam Pharmaceuticals, Inc.'s Revenue growth rate?
Over the last year, Alnylam Pharmaceuticals, Inc.'s Revenue growth was 21.5%. The average annual Revenue growth rates for Alnylam Pharmaceuticals, Inc. have been 54.2% over the past three years, 65.4% over the past five years.
3) Is Alnylam Pharmaceuticals, Inc.'s Revenue growth rate Good?
Over the last year, Alnylam Pharmaceuticals, Inc.'s Revenue growth was 21.5%, which is higher than industry growth of 3.1%. It indicates that Alnylam Pharmaceuticals, Inc.'s Revenue growth is Good.